Last spring, drugmaker Amgen Inc announced plans to buy Microsoft Corp’s Copilot AI assistant for 20,000 employees. It was a timely endorsement of the software company’s multibillion-dollar bet on generative artificial intelligence and Microsoft touted its new Copilot customer in three separate case studies.